Human Recombinant IL-1RA (from E. coli)

Lieferant: Shenandoah Biotechnology

100-195-20UG 100-195-100UG 100-195-250UG 100-195-500UG 100-195-1MG
SHBT100-195-20UGEA 86.9 CHF
SHBT100-195-20UG SHBT100-195-100UG SHBT100-195-250UG SHBT100-195-500UG SHBT100-195-1MG
Human Recombinant IL-1RA (from E. coli)
Proteine und Peptide

Interleukin-1 receptor antagonist (IL-1RA) binds the interleukin 1 receptor (IL-1R) to antagonize interleukin 1 alpha and beta signaling. IL-1RA is secreted by immune cells, epithelial cells, hepatocytes, and adipocytes to inhibit IL-1-induced inflammation. IL-1RA therapy is used to treat auto-inflammatory diseases such as diabetes and rheumatoid arthritis.


  • High quality
  • Low endotoxin
  • Affordable


IL-1RA is secreted by immune cells, epithelial cells, hepatocytes, and adipocytes to inhibit IL-1-induced inflammation. IL-1RA therapy is used to treat auto-inflammatory diseases such as diabetes and rheumatoid arthritis.


Lieferumfang: A COA is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.


Bitte beachten For research use only.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR